ANGELA RICE: Open Payments
NPI 1598121543 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 30 payments from 13 companies in 2025. Trend: 2023 $829 · 2024 $750 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
| Alnylam Pharmaceuticals Inc. | 5 | $85 |
| PFIZER INC. | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $28 |
| CVRx, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: ELIQUIS, ONPATTRO, JARDIANCE, VYNDAQEL, Wegovy, LEQVIO, REPATHA, LifeVest.
Industry payments across KS — which companies pay providers there.
